Clinical trial

Sleep and Tolerability Study: Comparing the Effects of Adderall XR and Focalin…

NCT00393042 · Seattle Children's Hospital, Other · Completed

Key facts

NCT number NCT00393042
Title Sleep and Tolerability Study: Comparing the Effects of Adderall XR and Focalin XR
Official title Sleep and Tolerability of Extended Release Dexmethylphenidate vs. Mixed Amphetamine Salts: A Double Blind, Placebo Controlled Study (SAT STUDY)
Lead sponsor Seattle Children's Hospital, Other
Collaborators Novartis Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Attention Deficit Hyperactivity Disorder
Intervention type Drug
Interventions Dexmethylphenidate, Mixed Amphetamine Salts, ER, placebo
Enrollment 77
Start date Jan 1, 2006
Primary completion Feb 1, 2009
Completion Feb 1, 2009
First posted Oct 26, 2006
Last update posted Apr 19, 2017
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies